Combination drug for topical administration, which includes indomethacin and troxerutin.
Indomethacin has a pronounced anti-inflammatory, analgesic and anti-edematous effect, leading to pain relief, reduction of edema and a reduction in the recovery time of the affected tissues. The main mechanism of action is associated with the suppression of the synthesis of prostaglandins by reversible blockade of cyclooxygenase 1 and 2.
Troxerutin (trihydroxyethylrutinoside) is a bioflavonoid. Provides angioprotective action.Reduces the permeability of capillaries and exhibits a venotonic effect. It blocks the venodilating effect of histamine, bradykinin and acetylcholine. It acts anti-inflammatory on perennial tissue, reduces the fragility of capillaries and has some anti-aggregative effect. Reduces puffiness, improves trophism with various pathological changes associated with venous insufficiency.
Triximethacin gel when applied to the skin suppresses the inflammatory edematous reaction, reduces pain and temperature in the foci of inflammation, located on the surface and in the depth, reaching the blood vessels located there. Has pronounced venotonic, capillaroprotective action.